Nanoparticle contrast agents for diagnostic imaging

Details for Australian Patent Application No. 2009334868 (hide)

Owner General Electric Company

Inventors Colborn, Robert Edgar; Bonitatibus Jr., Peter John; Torres, Andrew Soliz; Marino, Michael Ernest; Butts, Matthew David; Kulkarni, Amit; Bales, Brian C.; Hay, Bruce Allan

Agent Davies Collison Cave

Pub. Number AU-A-2009334868

PCT Pub. Number WO2010/076237

Priority 12/344,606 29.12.08 US; 12/344,608 29.12.08 US; 12/344,604 29.12.08 US

Filing date 18 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

A61K 49/18 (2006.01) Preparations for testing

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/076237 Priority application(s): WO2010/076237

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009334869-Substituted quinazoline compounds

2009334840-Dosing device